Visit

Hemp, Inc. Reports: Higher Education Aims to Harness Hemp’s Full Potential From Field to Fabric

Retrieved on: 
Tuesday, August 29, 2023
Heart, Building material, University, Farmer, Teaching, Clothing, Tobacco, Alabama A&M University, North Carolina State University, Movement, Visit, Fertility, OTC, Knowledge, Growth, Textile, Agriculture, Hemp

And now Alabama A&M University and North Carolina State University are continuing to shape the future trajectory of the hemp industry.

Key Points: 
  • And now Alabama A&M University and North Carolina State University are continuing to shape the future trajectory of the hemp industry.
  • It also addresses survey results from existing fiber hemp farmers who say their biggest challenges with the crop are planting density, weed management, and fertility.
  • (Credit/ Source )
    These initiatives stand as a testament to the expanding horizons of both farmers and the entire industry.
  • The company's diverse range of CBD/CBG/CBN products offers consumers a potent blend of therapeutic benefits.

Visit Korean Heritage Campaign 2023 Enchants Los Angeles

Retrieved on: 
Tuesday, August 29, 2023
Experience, Partnership, Travel, Drink, Korean Cultural Center New York, Culture, Bangladesh Technical Education Board, Korea Tourism Organization, CJ, Multimedia, Princess Hwahyeop, History of the Joseon dynasty, Visit, Korean wave, KCON, CJ ENM, Student, Beauty, Joseon, Crown Prince Sado, Sejong Institute, Social media, K-Beauty, Film industry, Tourism, Korean

SEOUL, South Korea, Aug. 29, 2023 /PRNewswire/ -- As part of the 2023 Visit KOREAN HERITAGE Campaign, the Cultural Heritage Administration of Korea and the Korea Cultural Heritage Foundation successfully concluded their second overseas event of the year in Los Angeles, California, U.S.A., from August 16 to 22.

Key Points: 
  • SEOUL, South Korea, Aug. 29, 2023 /PRNewswire/ -- As part of the 2023 Visit KOREAN HERITAGE Campaign, the Cultural Heritage Administration of Korea and the Korea Cultural Heritage Foundation successfully concluded their second overseas event of the year in Los Angeles, California, U.S.A., from August 16 to 22.
  • Launched in 2020, the Visit KOREAN HERITAGE Campaign is a branding initiative aimed at rediscovering the value of cultural heritage and the core elements of the global phenomenon of Hallyu (Korean Wave), while promoting the beauty of Korean cultural heritage both domestically and internationally.
  • At the event, the cultural heritage tourism program was introduced as part of the 2023 Visit KOREAN HERITAGE Campaign.
  • Moving forward, the Visit KOREAN HERITAGE Campaign plans to continue encouraging visits to Korean cultural heritage through various promotional events held in overseas locations.

Subsequent to the Release of Positive Phase 3 Trial Results, Vistagen Provides Corporate Update and Reports Fiscal 2024 First Quarter Financial Results

Retrieved on: 
Thursday, August 10, 2023
Biotechnology, Mental Health, Health, Pharmaceutical, Clinical Trials, Neuron, Hot, Optimism, Central nervous system, Depression, Nasal cavity, Anxiety, Aes, New Drug Application, Food and Drug Administration, Calendar, Clinical Global Impression, NDA, Woman, Subjective units of distress scale, SAD, Liebowitz social anxiety scale, Multimedia, Brain, CNS, Trial of the century, Visit, PALISADE, MDD, Patient, LSAS, Menopause, Social anxiety disorder, FDA, Fasedienol, Safety, Pharmaceutical industry, Nursing, Medical imaging, Dietary supplement, SUDS

Phase 3 study of an investigational therapy for social anxiety disorder in over 15 years,” said Shawn Singh, Chief Executive Officer of Vistagen.

Key Points: 
  • Phase 3 study of an investigational therapy for social anxiety disorder in over 15 years,” said Shawn Singh, Chief Executive Officer of Vistagen.
  • Positive Phase 3 PALISADE-2 study of fasedienol yields statistically significant top-line results for the acute treatment of anxiety in adults with SAD.
  • Based on the positive top-line results of the Phase 3 PALISADE-2 study, we are currently preparing for our Phase 3 PALISADE-3 trial, with potential to initiate the trial during the first half of calendar 2024.
  • Vistagen will host a conference call and live audio webcast this afternoon at 4:30 p.m. Eastern Time to provide a corporate update.

Vistagen Announces Positive Top-Line Results from Phase 3 PALISADE-2 Trial of Fasedienol (PH94B) Nasal Spray in Social Anxiety Disorder

Retrieved on: 
Monday, August 7, 2023
Biotechnology, Mental Health, Health, Pharmaceutical, Clinical Trials, Columbia University, Depression, Central nervous system, Liebowitz social anxiety scale, Anxiety, Aes, SAD, Medicine, CNS, New York State Psychiatric Institute, Visit, Patient, LSAS, Anxiety disorder, Social anxiety disorder, PH94B, Social anxiety, Fasedienol, Safety, Pharmaceutical industry, Nursing, Medical imaging, SUDS

The trial met its primary endpoint, with fasedienol demonstrating a statistically significant difference in average SUDS score during a public speaking challenge compared to placebo (p=0.015).

Key Points: 
  • The trial met its primary endpoint, with fasedienol demonstrating a statistically significant difference in average SUDS score during a public speaking challenge compared to placebo (p=0.015).
  • The trial also met its secondary endpoint, demonstrating a statistically significant difference in the proportion of clinician-assessed responders between fasedienol and placebo as measured by the CGI-I scale (p=0.033).
  • Fasedienol was well-tolerated and demonstrated a favorable safety profile consistent with all prior trials.
  • “As a new class of medicines, our pherine nasal spray pipeline holds the potential to transform the treatment landscape across numerous therapeutic areas.

Zambon Presents Results from the Two Phase 3 PROMIS Studies of CMS I-neb in Patients with Non-Cystic Fibrosis Bronchiectasis at World Bronchiectasis Conference 2023

Retrieved on: 
Tuesday, July 18, 2023
CMS, Registry, Bronchiectasis, QIDP, Safety, Efficacy, COVID-19, Saint George, Quality of life, Pseudomonas aeruginosa, LS, Visit, Incidence, AER, MILAN, AAD, Lower respiratory tract infection, Management, Health, FDA, Conference, Disease, Pharmaceutical industry, Poster, Patient

The trials explored the effect of CMS I-neb on the frequency of pulmonary exacerbations in NCFB patients chronically infected with P. aeruginosa.

Key Points: 
  • The trials explored the effect of CMS I-neb on the frequency of pulmonary exacerbations in NCFB patients chronically infected with P. aeruginosa.
  • A total of 377 patients were randomized, 177 to CMS I-neb and 200 to placebo.
  • "Results of PROMIS-II were unexpected in light of the positive data seen in PROMIS-I and the Phase 2 trial.
  • There are no approved inhaled treatments currently available for patients with bronchiectasis and P. aeruginosa infection.

Lay’s® Partners with Three Canadian Musicians to Launch Three Limited Edition Flavours

Retrieved on: 
Wednesday, June 7, 2023
Canadian Screen Award for Best Host in a Children's or Youth Program or Series, Hip, Lindsay, Crime, Miss, Philadelphia Cream Cheese, Visit, Screen Awards, Cucumber, Got Talent, Host, OG, Nachos, Female, Tea, Video game, Music, Cheese

As the OG brand that loves to change it up, the Lay’s® brand is officially launching Lay’s® Flavour Icons, three limited edition flavours inspired by fellow snack brands Doritos®, Smartfood®, and Miss Vickie’s®.

Key Points: 
  • As the OG brand that loves to change it up, the Lay’s® brand is officially launching Lay’s® Flavour Icons, three limited edition flavours inspired by fellow snack brands Doritos®, Smartfood®, and Miss Vickie’s®.
  • To celebrate, the Lay’s® brand is reinventing the iconic song Take On Me by A-ha and has partnered with three Canadian musicians to record their own take on the track in a genre inspired by each limited edition flavour.
  • These limited edition flavours are only available for a short time, so grab all three flavours while supplies last!
  • Lay’s® asked three Canadian musicians - City Fidelia , Crash Adams and Lindsay Ell - to reinvent the iconic song Take On Me by A-ha, each drawing inspiration from one of the limited edition flavours.

iCleanse Adds 30+ New Pilot Programs Including New England's Second Largest Airport to Its Growing National Customer List

Retrieved on: 
Tuesday, June 6, 2023
Olive, Aurora, Cloud, Advertising, Swift, Best Western, Airport, Harbor House (Nissequogue, New York), DOOH, Super 8 (hotel), American Distilling Institute, Visit, La Quinta Inns & Suites, Organization, OOH, Bradley International Airport, Hospital, AL, Restaurant, Garde Arts Center, Disinfectant, Candlewood Suites, Coffee, ARI, Sewage treatment, Hotel, Tourism

AVON, Conn., June 6, 2023 /PRNewswire-PRWeb/ -- iCleanse, the leading device disinfection and Digital Out of Home (DOOH) media company, announced today its first-of-its-kind disinfection product, Swift UV, has been installed in pilot programs at more than 30 locations nationwide.

Key Points: 
  • To date, more than 1 million phones have been disinfected and 1 million impressions delivered using iCleanse's Swift UV units.
  • "We're thrilled to add more than 30 pilot programs to our customer list as we continue to grow our digital OOH network into more high traffic venues," said iCleanse CEO Chris Allen.
  • Ad content can be fully customized and deployed across a fleet of units through the secure iCleanse Cloud.
  • Companies using iCleanse as an advertising and communication tool find they build sustainable brand loyalty and also expand their customer base.

Taking A New Journey To Reencounter My Cultural Heritage

Retrieved on: 
Thursday, May 11, 2023
Moonlight, National Palace Museum, Travel, Family Ties, Exhibition, Campaign, Wind wave, Culture, Seatrain, Late Autumn, COVID-19, The Korean Cultural Centre UK, Baekje, Culture of Korea, Information services, KOREA, Cosmetics, Multimedia, Korean wave, Visit, Korean Culture and Information Service, Beauty, Korea National University of Cultural Heritage, Korea National University of Arts, Intangibles, Transport, National Palace Museum of Korea, Tourism, Film industry, Korean, L.A

SEOUL, South Korea, May 11, 2023 /PRNewswire/ -- The Korea Cultural Heritage Administration and the Korea Cultural Heritage Foundation have jointly announced the commencement of the 2023 Visit KOREAN HERITAGE Campaign from May 9. The Campaign was inaugurated with a ceremony for campaign supporters held on May 9 at the Hwangudan Altar and the Westin Josun Seoul Hotel in Seoul.

Key Points: 
  • - The Campaign runs ten courses for cultural heritage tours to promote cultural heritage tourism through cooperation with accommodation, transportation, and travel industries
    SEOUL, South Korea, May 11, 2023 /PRNewswire/ -- The Korea Cultural Heritage Administration and the Korea Cultural Heritage Foundation have jointly announced the commencement of the 2023 Visit KOREAN HERITAGE Campaign from May 9.
  • With commencing the first year of restoration to daily life after the COVID-19 pandemic, the Campaign intends to provide visitors with an opportunity to enjoy cultural heritage and achieve a new quantum leap towards cultural heritage tourism.
  • The Cultural Heritage Visitors' Passport Tour program has undergone a complete renovation this year, marking the beginning of cultural heritage tourism in Korea.
  • Actress Kim Min-ha will serve as the campaign ambassador again this year to introduce the beauty of Korean cultural heritage.

CLA Repeats as Great Place to Work Winner

Retrieved on: 
Tuesday, January 31, 2023
Mental health, Growth, CliftonLarsonAllen, LLP, Family, Visit, CLA, Certification, Culture, Management

Charlotte, North Carolina, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Today, CLA (CliftonLarsonAllen LLP), the eighth largest accounting firm in the United States, announced it is again officially Great Place to Work-Certified™.

Key Points: 
  • Charlotte, North Carolina, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Today, CLA (CliftonLarsonAllen LLP), the eighth largest accounting firm in the United States, announced it is again officially Great Place to Work-Certified™.
  • CLA also was named a Great Place to Work in 2022.
  • “At CLA, we believe our culture is a competitive advantage,” said Jen Leary, CLA CEO.
  • We are honored to see how these efforts were recognized in our employees naming CLA a great place to work.”
    CLA’s 2023 score is 87%, which is 30 points higher than the average of other U.S. companies, according to Great Place to Work.

Ubiquity Earns Great Place to Work Certification™ for Second Consecutive Year

Retrieved on: 
Wednesday, January 18, 2023
Software, Human Resources, Consulting, Outsourcing Business, Professional Services, Technology, Other Technology, Business, Visit, Trust, Community, Certification, Workplace, Environment, Geography, BPO, Great Places, Growth, Multimedia, Management, Ubiquity

Ubiquity , a leading global business process outsourcer, has been recognized as a Great Place to Work®-Certified company for the second consecutive year.

Key Points: 
  • Ubiquity , a leading global business process outsourcer, has been recognized as a Great Place to Work®-Certified company for the second consecutive year.
  • Based solely on employee feedback from the Great Place to Work Trust Index® Survey, the certification measures multiple aspects of the employee experience, including maximizing human potential through effective leaders, meaningful values, and a deep foundation of trust.
  • View the full release here: https://www.businesswire.com/news/home/20230118005870/en/
    Ubiquity recognized as Great Place to Work for second consecutive year (Photo: Business Wire)
    Nearly 2,000 more Ubiquity employees participated in the 2022 survey, as the company’s headcount grew nearly 50% between survey periods.
  • Additionally, employees at certified workplaces are 93% more likely to look forward to coming to work, and employees have twice the opportunities for promotion.